Literature DB >> 18788435

[A case of endobronchial actionomycosis evaluated by FDG-PET].

Hirokazu Tokuyasu1, Tomoya Harada, Etsuko Watanabe, Hirokazu Touge, Yuji Kawasaki, Noritaka Isowa, Eiji Shimizu.   

Abstract

In April 2005, a 78-year-old man was admitted to our hospital because an abnormal chest shadow had been noted on a medical examination. Our investigation revealed primary squamous cell lung carcinoma in the right lower lobe (stage IIIA). Right middle and lower lobectomies including resection of the chest wall were performed. 18Fluorodeoxyglucose-positron emission tomography (FDG-PET) conducted 18 months later demonstrated nodular lesions with intense FDG activity in the right upper lobe and the presence of a post-resection positive bronchial stump. Fiberoptic bronchoscopic examination revealed a pus-coated mass located in the endobronchial lesion, and Actinomyces was identified in a biopsy specimen of the mass. Endobronchial actinomycosis was diagnosed. An FDG-PET examination conducted after the patient was treated with amoxicillin (AMPC) for 2 months, did not indicate any FDG activity in the endobronchial lesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18788435

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Unexpected positron emission tomography-positive actinomyces-related mass of the bronchial stump.

Authors:  Alessandro Andreani; Giulio Rossi; Michele Giovannini; Gaia Francesca Cappiello
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.

Authors:  Arthur Cho; Jin Hur; Won Jun Kang; Ho Jin Cho; Jae-Hoon Lee; Mijin Yun; Jong Doo Lee
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

3.  Pulmonary actinomycosis mimicking lung cancer on positron emission tomography.

Authors:  Hayoung Choi; Hyun Lee; Suk Hyeon Jeong; Sang-Won Um; O Jung Kown; Hojoong Kim
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.